U.S. Physical Therapy, Inc. (NYSE:USPH) Receives $109.00 Consensus Target Price from Brokerages

Key Points

• U.S. Physical Therapy, Inc. has received an average recommendation of "Buy" from six brokerages, with a 12-month price target of $109.00.
• The company recently reported earnings of $0.48 per share for the last quarter, exceeding analysts' expectations and achieving an 18.0% year-over-year revenue increase.
• A dividend of $0.45 per share was declared, providing shareholders with an annual yield of 2.40% and a payout ratio of 82.57%.

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) have been assigned a consensus rating of "Buy" from the six ratings firms that are currently covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation, four have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $109.00.

Several equities research analysts have recently issued reports on USPH shares. Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. Barrington Research reiterated an "outperform" rating and issued a $98.00 target price on shares of U.S. Physical Therapy in a report on Tuesday, July 1st. Finally, JMP Securities reiterated a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd.

U.S. Physical Therapy Price Performance

NYSE USPH traded down $2.94 during mid-day trading on Thursday, hitting $70.21. The stock had a trading volume of 151,519 shares, compared to its average volume of 180,628. U.S. Physical Therapy has a 52-week low of $62.77 and a 52-week high of $101.19. The company has a market cap of $1.07 billion, a price-to-earnings ratio of 32.21, a P/E/G ratio of 3.39 and a beta of 1.45. The company has a 50 day simple moving average of $76.20 and a 200 day simple moving average of $77.48. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.32.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.02. The company had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. U.S. Physical Therapy had a return on equity of 7.89% and a net margin of 4.57%. U.S. Physical Therapy's revenue was up 18.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.51 earnings per share. Equities analysts forecast that U.S. Physical Therapy will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Friday, May 23rd were given a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend was Friday, May 23rd. U.S. Physical Therapy's payout ratio is presently 82.57%.

Insider Activity

In other news, Director Nancy Ham sold 400 shares of U.S. Physical Therapy stock in a transaction dated Thursday, June 12th. The stock was sold at an average price of $78.01, for a total transaction of $31,204.00. Following the sale, the director directly owned 2,594 shares of the company's stock, valued at approximately $202,357.94. The trade was a 13.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 2.00% of the company's stock.

Institutional Trading of U.S. Physical Therapy

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Point72 Asset Management L.P. acquired a new position in shares of U.S. Physical Therapy during the fourth quarter worth approximately $18,886,000. Nuveen LLC acquired a new position in shares of U.S. Physical Therapy during the first quarter worth approximately $8,702,000. Bahl & Gaynor Inc. boosted its position in shares of U.S. Physical Therapy by 32.6% during the first quarter. Bahl & Gaynor Inc. now owns 345,003 shares of the company's stock worth $24,964,000 after buying an additional 84,878 shares during the period. Copeland Capital Management LLC boosted its position in shares of U.S. Physical Therapy by 8.9% during the second quarter. Copeland Capital Management LLC now owns 888,735 shares of the company's stock worth $69,499,000 after buying an additional 72,463 shares during the period. Finally, Raymond James Financial Inc. acquired a new position in shares of U.S. Physical Therapy during the fourth quarter worth approximately $6,240,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.